Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
User

Mark A. Hillman

Hillman Value Fund

Hillman Value Fund Portfolio 13F

Mark A. Hillman Holdings Activity

Portfolio value:
$179.89M≈ (-$29M≈)
Previous value:
$208.50M≈
# of changes:
12
New positions:
1
Reported for:
30 Sep 2022 (Q3)
Latest filing date:
29 Nov 2022
Hillman Value Fund has disclosed a total of 12 changes to the portfolio in the (2022 Q3) SEC report(s): increased the number of shares of 3, bought 1 totally new, decreased the number of shares of 7 and completely sold out 1 position(s).

What stocks did Mark A. Hillman buy in 2022 Q3?

During 2022 Q3 Mark A. Hillman has purchased 4 securities: (UMBXX) MONEY MARKET FIDUCIA (added shares +125.51%), (GSK) GlaxoSmithKline PLC ADR (added shares +35.05%), (TSM) Taiwan Semiconductor Manufacturing (new buy) and (INTC) Intel Corp (added shares +1.27%).

What did Mark A. Hillman invest in during 2022 Q3?

Mark A. Hillman's top 5 holdings (by % of portfolio) were (UMBXX) MONEY MARKET FIDUCIA (3.95%), (CVS) CVS Health Corp (3.45%), (WFC) Wells Fargo & Company (3.30%), (CAG) Conagra Brands, Inc (3.17%) and (ZBH) Zimmer Biomet Holdings Inc (3.08%).
In the 2022 Q3 report(s) the following changes have been made to the top investments: (UMBXX) MONEY MARKET FIDUCIA (added shares +125.51%) and (CAG) Conagra Brands, Inc (reduced shares -12.50%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.